1. Anaphylactoid reactions to ciprofloxacin

   Newsletter Article 27 January 2013 Pages: 1 - 1

2. Comparing ACE inhibitor safety profiles

   Newsletter Article 27 January 2013 Pages: 1 - 1

3. Prostaglandins demonstrate no advantage over H2-antagonists in terms of safety

   Newsletter Article 27 January 2013 Pages: 2 - 2

4. Aspects of theophylline poisoning

   Newsletter Article 27 January 2013 Pages: 3 - 3

5. Antacids

   Newsletter Article 27 January 2013 Pages: 4 - 4

6. Antineoplastics ± radiotherapy

   Newsletter Article 27 January 2013 Pages: 4 - 4

7. Antipsychotics see Lithium/antipyschotics

   Newsletter Article 27 January 2013 Pages: 4 - 4

8. Benzodiazepines

   Newsletter Article 27 January 2013 Pages: 4 - 4

9. Bismuth

   Newsletter Article 27 January 2013 Pages: 4 - 4

10. Bismuth subgallate

    Newsletter Article 27 January 2013 Pages: 5 - 5

11. Busulfan

    Newsletter Article 27 January 2013 Pages: 5 - 5

12. Carboplatin

    Newsletter Article 27 January 2013 Pages: 5 - 5

13. Ciprofloxacin

    Newsletter Article 27 January 2013 Pages: 5 - 5

14. Cisplatin

    Newsletter Article 27 January 2013 Pages: 5 - 5

15. Cocaine abuse

    Newsletter Article 27 January 2013 Pages: 5 - 5

16. Cotrimoxazole see Warfarin interaction

    Newsletter Article 27 January 2013 Pages: 5 - 5

17. Dextran

    Newsletter Article 27 January 2013 Pages: 5 - 5

18. Fenbufen

    Newsletter Article 27 January 2013 Pages: 5 - 5

19. Haemophilus influenzae type b vaccine

    Newsletter Article 27 January 2013 Pages: 5 - 6

20. Ifosfamide

    Newsletter Article 27 January 2013 Pages: 6 - 6

21. Insulin overdose

    Newsletter Article 27 January 2013 Pages: 6 - 6

22. Interleukin 2

    Newsletter Article 27 January 2013 Pages: 6 - 6

23. Lithium

    Newsletter Article 27 January 2013 Pages: 6 - 6

24. Lithium/antipsychotics

    Newsletter Article 27 January 2013 Pages: 6 - 7

25. Methotrexate

    Newsletter Article 27 January 2013 Pages: 7 - 7

26. Methylprednisolone

    Newsletter Article 27 January 2013 Pages: 7 - 8

27. Methyltestosterone

    Newsletter Article 27 January 2013 Pages: 8 - 8

28. Neuroleptics

    Newsletter Article 27 January 2013 Pages: 8 - 8

29. Nifedipine

    Newsletter Article 27 January 2013 Pages: 8 - 8

30. Nitroglycerin

    Newsletter Article 27 January 2013 Pages: 8 - 8

31. Ofloxacin

    Newsletter Article 27 January 2013 Pages: 8 - 9

32. Propofol

    Newsletter Article 27 January 2013 Pages: 9 - 9

33. Ranitidine

    Newsletter Article 27 January 2013 Pages: 9 - 9

34. Ranitidine see Warfarin interaction

    Newsletter Article 27 January 2013 Pages: 9 - 9

35. Rioprostil

    Newsletter Article 27 January 2013 Pages: 9 - 9

36. Streptokinase

    Newsletter Article 27 January 2013 Pages: 9 - 10

37. Sulfasalazine

    Newsletter Article 27 January 2013 Pages: 10 - 10

38. Sulfonylureas

    Newsletter Article 27 January 2013 Pages: 10 - 10

39. Trihexyphenidyl

    Newsletter Article 27 January 2013 Pages: 10 - 10

40. Trimetaphan camsylate

    Newsletter Article 27 January 2013 Pages: 10 - 10

41. Warfarin interaction

    Newsletter Article 27 January 2013 Pages: 10 - 11

42. Zidovudine

    Newsletter Article 27 January 2013 Pages: 11 - 11

43. Complications of asthma therapy

    Newsletter Article 27 January 2013 Pages: 12 - 12